For over sixty years Dr. Robert Kyle, MD of the Mayo Clinic led the way in myeloma research and was the pioneer that defined and determined early precursor conditions MGUS and smoldering myeloma in the late 1970s and early 1980s.  He joins us to share over 40 years of data from an extensive longitudinal study and his key findings on these precursor conditions of multiple myeloma. Dr. Kyle's groundbreaking work has changed how smoldering myeloma is diagnosed and treated. Learn what deep expertise can tell us about myeloma progression from these early stages and what it means for you. Special thanks to our episode sponsor, Takeda Oncology